Literature DB >> 8471797

Repeated injections of interferon-alpha A/D in Balb/c mice: behavioral effects.

A L Dunn1, L S Crnic.   

Abstract

Interferon-alpha decreases food intake and activity in mice and humans. The present study further explores parallels between effects of this protein in humans and mice, using a hybrid recombinant interferon-alpha A/D (INF-alpha A/D) that has antiviral and hepatic activity in mice. Measures of activity (open field), muscle strength (forelimb grip strength), and motor ability (swim posture and endurance with 0, 3, and 6% added weight) were examined in Balb/c mice injected with 1600 U/g of hybrid rhuIFN-alpha A/D daily for 5 days (n = 9) or with IFN vehicle (n = 11). Open field activity was significantly depressed in the group exposed to IFN. The number of times the nose dipped under the water when swimming with 3% added body weight was higher in the IFN-treated mice, while float time was decreased with 6% added weight. The IFN-treated mice were slower to adopt the new strategies necessary to swim with added weight. Depression of motor activity is a robust, general effect of IFN treatment observed in this as well as previously published studies. Together, these studies demonstrate activity decrements in two different strains of mice, two different activity measures, acute and chronic injections, and recombinant and nonrecombinant IFN preparations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471797     DOI: 10.1006/brbi.1993.1011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  12 in total

Review 1.  Inflammation-associated depression: from serotonin to kynurenine.

Authors:  Robert Dantzer; Jason C O'Connor; Marcus A Lawson; Keith W Kelley
Journal:  Psychoneuroendocrinology       Date:  2010-10-30       Impact factor: 4.905

2.  Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.

Authors:  Francis E Lotrich; Robert E Ferrell; Mordechai Rabinovitz; Bruce G Pollock
Journal:  Biol Psychiatry       Date:  2008-09-18       Impact factor: 13.382

3.  Effect of interferon-alpha on DOI-induced wet-dog shakes in rats.

Authors:  A Kugaya; A Kagaya; Y Uchitomi; N Yokota; S Yamawaki
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

5.  Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.

Authors:  S Abe; T Hori; T Suzuki; A Baba; H Shiraishi; T Yamamoto
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

6.  Evaluation of the effects of chemotherapy-induced fatigue and pharmacological interventions in multiple mouse behavioral assays.

Authors:  John P Dougherty; Danielle A Springer; Mary J Cullen; Marvin C Gershengorn
Journal:  Behav Brain Res       Date:  2018-12-07       Impact factor: 3.332

7.  Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor.

Authors:  Cari F Kessing; William R Tyor
Journal:  J Interferon Cytokine Res       Date:  2014-12-17       Impact factor: 2.607

8.  Decreased immobility in swimming test by homologous interferon-alpha in mice accompanied with increased cerebral tryptophan level and serotonin turnover.

Authors:  Jianping Wang; Adrian J Dunn; Amanda J Roberts; Hua Zhang
Journal:  Neurosci Lett       Date:  2009-01-24       Impact factor: 3.046

9.  Interferon-alpha causes neuronal dysfunction in encephalitis.

Authors:  Andrew R Sas; Heather Bimonte-Nelson; C Thetford Smothers; John Woodward; William R Tyor
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

10.  Psychiatric clearance for patients started on interferon-alpha-based therapies.

Authors:  Francis E Lotrich
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.